Skip to main content

Underwriting and genetics

Can Life Insurers Use Your DNA Test? The State Rules, Checked October 2026

Underwriting and health · Updated October 31, 2026

Federal law does not stop a life insurer from asking about or using genetic test results. The Genetic Information Nondiscrimination Act of 2008 (GINA) protects you in health insurance and in employment, and the words "life insurance" appear nowhere in it. Protection for life insurance applicants comes from state law, and it varies sharply. Florida bars life insurers from requiring, soliciting or using genetic test results for any insurance purpose. Delaware, since a law approved October 9, 2024, bars life insurers from denying or surcharging coverage based solely on a genetic test and from asking for consumer DNA test data. Maryland, Illinois, South Dakota, Arizona and Vermont set narrower rules on testing, consent or data sharing. In most other states, a life insurer that asks the question is entitled to a truthful answer.

Take two hypothetical applicants with the same consumer DNA report, each showing a variant linked to a raised risk of a heart condition, and neither with any symptom or diagnosis. One lives in Florida. The other lives in a state with no genetic-specific insurance statute. The Florida insurer may not ask about the report, may not use it, and may not hold the decision to take the test against the applicant, under section 627.4301(2)(b) of the Florida Statutes. The other insurer may include a genetic testing question on its application, and a false answer there carries the same risk as any other false answer during the contestable period. Same report, same health, different legal footing, decided by the state where the policy is issued.

Sources and dates: how we check each figure.

What GINA covers, and where it stops

GINA is Public Law 110-233, signed May 21, 2008. Its table of contents shows its reach in two titles. Title I, "Genetic Nondiscrimination in Health Insurance," amends the Employee Retirement Income Security Act, the Public Health Service Act, the Internal Revenue Code and the Medicare supplement (Medigap) rules. Title II, "Prohibiting Employment Discrimination on the Basis of Genetic Information," covers employers, employment agencies, labor organizations and training programs. Title III holds severability and a child labor provision. Nothing in the Act addresses life insurance, disability income insurance or long-term care insurance.

The definitions in Title II, codified at 42 U.S.C. 2000ff, show how broad "genetic information" is in the places where GINA does apply. It covers an individual's own genetic tests, the genetic tests of family members, and the manifestation of a disease or disorder in family members, which is family medical history. A "genetic test" is "an analysis of human DNA, RNA, chromosomes, proteins, or metabolites, that detects genotypes, mutations, or chromosomal changes." A consumer saliva kit that reports variants fits that definition.

So the protection is real but bounded. Your employer may not ask for your consumer DNA results to decide whether to hire you, and your health plan may not price your coverage on them. Neither rule follows you into a life insurance application. The Rhode Island bill discussed below says this in its own findings: GINA, as codified at 29 U.S.C. 1182, protects health insurance, and the bill exists because nothing equivalent protects life, disability or long-term care coverage.

One overlap is worth knowing. Group life insurance bought through work is still life insurance. GINA's employment title limits what your employer does with genetic information, but the insurer that underwrites any evidence-of-insurability form for supplemental group coverage is governed by state insurance law, not by GINA.

The state rule table, checked October 31, 2026

Each row below was read from the state's official legislature or insurance department site on October 31, 2026. The table covers the states whose statute text could be read there. It is not a 50-state survey, and a state missing from it may still have a general unfair discrimination rule that applies to genetic information.

StateCitationWhat a life insurer may not doWhat stays allowedStatus on Oct 31, 2026
FloridaFla. Stat. 627.4301 (last amended by ch. 2020-159, Laws of Florida)Cancel, limit or deny coverage or set premium differentials on genetic information absent a related diagnosis; require or solicit genetic information; use genetic test results; consider a person's decisions or actions about testing "in any manner for any insurance purpose"Accessing the medical record as part of an application exam; considering a diagnosis in that record, even one made on a genetic testIn force (2026 Florida Statutes)
Delaware18 Del. C. 2317A, added by 84 Del. Laws c. 481 (the Ericka Byler Act)Deny, cancel, restrict, surcharge or otherwise discriminate based solely on genetic information from a test; require or request a genetic test; request consumer DNA test data or consent to share it; obtain data from a consumer testing company without written informed consentGenetic information, test results or family history already in the medical recordApproved October 9, 2024; in the current Delaware Code
MarylandMd. Code, Insurance 27-909.1Base rates or coverage on medical information, including genetic test results, that has no relationship to the cost of the risk; access genetic data without signed written consent; mandate genetic testing or genome sequencing (not waivable)Accessing the medical record; considering a diagnosis even if based on a genetic test; rating that rests on actuarially sound principles or experienceIn force; effective October 1, 2025, per the Maryland Insurance Administration
Illinois410 ILCS 513/20(e), Genetic Information Privacy ActThe rule binds the testing company: a direct-to-consumer genetic testing company may not share genetic test information or other identifying data with a life (or health) insurer without the consumer's written consentSharing with written consent; the Act's insurer-use limits are written around accident and health policiesCurrent text from P.A. 101-132, effective January 1, 2020; amended text adding biomarker testing takes effect January 1, 2027 (P.A. 104-642)
South DakotaSDCL 58-1-25, 58-1-25.1; SDCL 37-24-59 to 37-24-64Require or request a genetic test of the applicant or a blood relative; consider a refusal to test. A consumer testing company may not share genetic data with a life insurer without written consentUnderwriting on the medical record; nothing bars use of results the applicant discloses58-1-25 and 25.1 effective January 1, 2022; the consumer genetic data act enacted in the 2026 session (SL 2026, ch. 164)
ArizonaA.R.S. 20-448(D), (E); 20-448.02Refuse to consider an application on the basis of a genetic condition; reject or rate on a genetic condition unless medical history plus claims experience or actuarial projections show a substantial difference in claims; order a genetic test without specific written informed consentActuarially supported rating; release of results with the subject's express consentIn force
Vermont18 V.S.A. 9334Underwrite or condition any policy on a requirement to undergo genetic testing, or on the genetic test results of a family memberThe statute does not address the applicant's own existing resultsIn force since January 1, 1999 (Act No. 160 of the 1997 Adjourned Session); no later amendment
Rhode IslandH 7861 (2026), proposed R.I. Gen. Laws 27-4-4.1Would bar life, disability and long-term care insurers from requiring, soliciting or using genetic test results absent a clinical diagnosis or manifestation of diseaseWould keep medical record review, family history questions and diagnosed conditionsBill only: introduced February 27, 2026, referred to House Corporations; no section 27-4-4.1 in the chapter index

Three patterns sit in that table. Florida and Delaware restrict the insurer's use of results. Maryland and Arizona allow use only when it tracks the actual risk and limit how tests are obtained. Illinois and South Dakota put the duty on the testing company, so an insurer cannot buy or receive your kit data without your written consent, but nothing in those sections forbids an insurer from asking you directly.

Florida's text, read clause by clause

Florida's section 627.4301 is the broadest of the enacted laws, and its clauses do different jobs. Subsection (1)(a) defines "genetic information" as information from genetic testing about variations or mutations, including carrier status, that are believed to cause a disease or raise its risk, where the condition "is asymptomatic at the time of testing." The definition excludes routine physical examinations and blood or urine chemistry unless they are run to obtain genetic information, and it excludes "questions regarding family history." A Florida application may still ask whether your parents had heart disease.

Subsection (2)(a) is the classic anti-discrimination clause: absent a diagnosis of a related condition, a life insurer may not cancel, limit or deny coverage, or set premium differentials, on genetic information. Subsection (2)(b) goes further than most state laws. A life insurer may not "require or solicit genetic information, use genetic test results, or consider a person's decisions or actions relating to genetic testing in any manner for any insurance purpose." "Solicit" means the insurer should not be asking, and "decisions or actions relating to genetic testing" means it should not draw conclusions from the fact that you tested, chose not to, or saw a genetic counselor.

Subsection (2)(d) is the limit. A life insurer may access your medical record as part of an application exam, and it may consider "a medical diagnosis included in an individual's medical record, even if a diagnosis was made based on the results of a genetic test." If a doctor has diagnosed you with a condition, the diagnosis is underwriting information in Florida, whatever test led to it. The exclusions in (2)(c) cover accident-only, hospital or fixed indemnity, dental and vision policies, none of which is life insurance.

A stale claim that Florida is the only state with such a law circulates widely. Delaware's 2024 statute uses different words but reaches many of the same acts, and Maryland's 2025 rules add a consent requirement and a testing ban that cannot be waived. Florida's text remains the widest, because it covers asking, using and drawing inferences from the decision to test.

Delaware's 2024 law and its medical-record carve-out

Delaware's General Assembly passed House Substitute 1 for House Bill 286, approved October 9, 2024, as volume 84, chapter 481 of the Laws of Delaware. It added section 2317A to Title 18, covering "contracts for life insurance and annuities." The act calls itself "The Ericka Byler Act."

Subsection (b) bars a life insurer from denying, refusing to issue or renew, cancelling or restricting a policy, adding a surcharge or rating factor, or "otherwise discriminat[ing]" in price, amount, claims or other conditions, when the action is "based solely on any genetic characteristic or genetic information contained in the result of any genetic test." The word "solely" matters, and the third clause adds "without additional actuarial justification." An insurer acting on a combination of findings is in a different position from one acting on a gene report alone.

Subsection (c) then removes from (b) any genetic characteristic, information or test result "that is in an individual's medical record or pertinent family history." That carve-out is wider than Florida's. Florida protects the result and lets the insurer use a diagnosis; Delaware lets the insurer use a result that has made its way into your chart. A consumer kit you never showed a doctor is protected. A clinical panel your physician ordered and filed is not.

Subsections (d) and (e) close the consumer-kit doors. A Delaware life insurer may not require or request that you or a relative take a genetic test, may not consider a refusal, may not request genetic information from a direct-to-consumer testing company or your consent for that company to share it, and may not obtain information from such a company without written informed consent under section 1202 of Title 16. The current Delaware Code, read on October 31, 2026, carries section 2317A with its 2024 source note.

The Maryland Insurance Administration's consumer advisory says that starting October 1, 2025, life and disability income insurers in Maryland "cannot use your genetic information as a reason to deny you coverage." The statute it describes, section 27-909.1 of the Insurance Article, is worded more narrowly, and the statute is what binds an insurer.

Paragraph (c)(1) says a life or disability insurer may not "unfairly discriminate" by conditioning rates, coverage or other terms on medical information, including genetic test results, "for which there is not a relationship between the medical information and the cost of the insurance risk." Paragraph (c)(2) lets the insurer show that relationship through "actuarially sound principles or actual or reasonably anticipated experience." That is a justification standard. A result with a demonstrated link to mortality is not automatically off limits.

The firmer protections are in (c)(3) and (c)(4). A Maryland life insurer may not access sensitive medical information, "including the genetic data of an individual," without your signed, written consent, and may not "mandate existing or new genetic testing or full genome sequencing" as a condition of eligibility or coverage. Paragraph (c)(4) says neither the insurer nor the applicant may waive the testing ban "under any circumstances," so a form you sign cannot trade it away. Paragraph (b)(2) preserves access to the medical record and use of a diagnosis "even if the diagnosis was based on the results of a genetic test."

For a Maryland applicant, the practical reading is: no insurer can make you test or look at your genetic data without your signature, and any use of a result has to rest on a demonstrated link to risk. A complaint goes to the Insurance Administration, which the statute empowers to issue orders under sections 4-113, 4-114, 27-501 and 27-505.

Illinois and South Dakota: rules aimed at the testing company

Illinois's Genetic Information Privacy Act limits insurers mostly in the health context. Section 20(a) bars an insurer from seeking genetic testing information "for use in connection with a policy of accident and health insurance," and the "underwriting purposes" definition in 20(b) ends with activities related to "a contract of health insurance or health benefits." Section 20(e) reaches life insurance: a company providing direct-to-consumer genetic testing "is prohibited from sharing any genetic test information or other personally identifiable information about a consumer with any health or life insurance company without written consent from the consumer." The section's current text dates from P.A. 101-132, effective January 1, 2020. Public Act 104-642 rewrites it to add biomarker testing and biomarker information, effective January 1, 2027.

South Dakota's rules work in two layers. Section 58-1-25, as amended effective January 1, 2022, bars a life insurer from requiring or requesting a genetic test of you or a blood relative and from considering a refusal. Section 58-1-25.1 bars any company providing genetic testing directly to consumers from sharing genetic information with a life insurer without written consent. In 2026 the Legislature added a wider consumer genetic data law at sections 37-24-59 through 37-24-64 (Session Laws 2026, chapter 164). It requires a testing company to obtain separate express consent, naming the recipient, for each transfer of genetic data or a biological sample to anyone other than its vendors and service providers, and it sets a civil penalty of up to $5,000 per violation.

None of these sections tells an insurer it may not ask you. A South Dakota insurer may not request that you take a test, but section 58-1-25 does not mention results you already have. An Illinois life insurer's application question about prior testing is not addressed by section 20(e), which governs the testing company. What both states guarantee is that your kit data should not reach an insurer behind your back.

Arizona's insurance code handles genetics inside its unfair discrimination section. Section 20-448(D) bars an insurer from refusing to consider a life or disability application "on the basis of a genetic condition." Section 20-448(E) makes rejection or rating on a genetic condition unfair discrimination "unless the applicant's medical condition and history and either claims experience or actuarial projections establish that substantial differences in claims are likely to result." Section 20-448.02 requires specific written informed consent, on a form prescribed by the director, before anyone orders or requires a genetic test, and makes results privileged and confidential except with the subject's express consent.

Vermont's section 9334 of Title 18, added by Act No. 160 of the 1997 Adjourned Session and effective January 1, 1999, bars underwriting or conditioning "any policy of insurance" on a requirement that you undergo genetic testing, or on "the results of genetic testing of a member of the individual's family." It reaches life insurance because it reaches every policy, but it does not mention an applicant's own existing results. A violation is treated as an unfair or deceptive practice under 8 V.S.A. 4724.

Which measures passed, and which did not

Pending bills are where outdated articles go most wrong in both directions, either calling a passed law a proposal or treating a proposal as law. Here is where four measures stood on October 31, 2026.

  • Delaware HB 286 passed. The session law is volume 84, chapter 481, approved October 9, 2024, and it is in the current code.
  • Maryland's measure passed. Section 27-909.1 is in the Insurance Article, and the Insurance Administration gives October 1, 2025 as the date the protections began.
  • Vermont S.247 (2022) did not. The bill, "An act relating to prohibiting discrimination based on genetic information," passed the Senate in 2022. The legislature's bill status page shows "No act information found for S.247 in the Regular Session 2021-2022," and section 9334 still carries only its original source line.
  • Rhode Island H 7861 (2026) is a bill. Introduced February 27, 2026 and referred to House Corporations, it would add section 27-4-4.1 with Florida-style language for life, disability and long-term care insurers. The General Assembly's index for chapter 27-4 did not list that section on October 31, 2026.

A bill you read about in the news protects nobody until it is enacted and in force. To check your own state, look up the insurance title of its code on the legislature's site and search for "genetic," then read the source note at the foot of each section for the year it was added or changed.

A test result versus a diagnosis in your chart

Every enacted law in the table, and the Rhode Island bill, draws the same line: genetic information before any diagnosis is treated differently from a diagnosed condition. Florida's (2)(d), Maryland's (b)(2), Rhode Island's proposed (c)(3) and, more broadly, Delaware's (c) all leave the medical record and its diagnoses available to the underwriter.

That line explains most real cases. A consumer kit reporting a variant, with no symptoms and no physician involvement, is "genetic information" in the narrowest sense, and it is where state protection is strongest. A clinical genetic test ordered by a physician, documented in your chart and followed by a surveillance plan, is part of your medical history. Once a condition is diagnosed, whether through symptoms, imaging, bloodwork or a genetic test, it is underwriting information in every state in the table, subject in Maryland and Arizona to the insurer's showing that it bears on risk.

Family history is a third category. Florida's definition excludes "questions regarding family history," Delaware's carve-out names "pertinent family history," and Rhode Island's bill says nothing in it prohibits family history questions. Under GINA, family medical history is genetic information for health insurance purposes, but that federal definition does not carry over to life insurance. Expect a family history question on most applications, and answer it from what you actually know about your relatives' diagnoses. Our health classes explainer covers how family history enters the class decision.

Does the application ask? A decision rule

The legal rules above matter most at one moment: when you read the application. Underwriters work from your answers and the records you authorize, and the obligation on you is to answer what is asked, accurately. A licensed agent in your state can tell you what a specific insurer's form asks before you apply. This site does not sell insurance, does not provide quotes and does not predict how any insurer will underwrite your application, and the statute text in your state, with your policy contract, controls over any summary here.

What you seeWhat the rules meanWhat to do
No question about genetic testing anywhere on the application or in the medical questionnaireYou have no duty to volunteer a result nobody asked about. A diagnosis is still caught by the ordinary medical history questions.Answer every medical question accurately, including diagnoses that followed a genetic test. Do not add an unasked disclosure about a kit.
A question about genetic testing, and you live in FloridaSection 627.4301(2)(b) bars a life insurer from soliciting genetic information.Ask the agent or insurer in writing why the question appears, and raise it with Florida's insurance regulator if the answer does not resolve it. Do not answer falsely.
A request for consumer DNA data, or consent to obtain it, and you live in DelawareSection 2317A(d) bars the insurer from requesting either, or considering a refusal.Decline the request; the insurer may not hold the refusal against you. Answer the medical record questions accurately.
A requirement to take a genetic testBarred in Delaware, Florida, Maryland (not waivable), South Dakota and Vermont; in Arizona it needs specific written informed consent.In those states, decline and raise it with the agent or the state insurance department.
A question about prior genetic testing in a state with no specific ruleNo statute in the table stops the question. A false answer is a misstatement on the application.Answer truthfully. If you are unsure what the question covers, ask in writing before you sign.
An authorization to release medical recordsRecords that include a genetic result can reach the underwriter; Maryland requires signed written consent before access to genetic data.Read the authorization's scope. Know what is in your chart before you sign.

The rule that holds everywhere: answer the question on the form, as asked, as of the date you sign. Florida protects you from being asked. Delaware protects you from being asked for kit data and from a decision based on the result alone. In the states without a specific statute, your protection is the question's wording, so read it closely. A question about "genetic testing for a disease" and a question about "any genetic test, including ancestry services" ask for different things.

A false answer is the expensive answer

Life insurance contracts carry a contestable period, commonly the first two years, during which the insurer may investigate a claim and rescind the policy for a material misstatement on the application. A genetic testing question is no exception in a state that permits it. If the form asked whether you had ever had a genetic test, you answered no, and the claim file turns up a kit result, the insurer can raise the misstatement as it would a hidden diagnosis. Our beneficiaries and contestability guide explains how the period works.

The opposite mistake is less costly but still avoidable: volunteering a consumer DNA report in a state like Florida or Delaware, where the insurer may not use it, or attaching raw data to an application nobody asked for. Unrequested paper in the file does not help the underwriter and can raise follow-up requests. Answer what is asked.

If an application is declined or rated and you believe a genetic result played a part, the insurer's adverse decision letter and your right to the records used are the starting points. Our guide to what to do after a life insurance application is denied sets out the reasons letter, the records requests and the order of next steps.

A policy already in force

A genetic test taken after your policy is issued does not change the policy. A life insurance contract fixes its premium schedule, face amount and terms at issue; it does not give the insurer a right to re-underwrite you when your health information changes. A level term policy keeps its scheduled premiums whether you later take a consumer DNA test, get a clinical diagnosis or develop a serious illness. Nothing in the policy obliges you to report new health information after issue.

Two moments reopen the question. The first is the gap between application and delivery. Some insurers ask you to confirm at delivery that your health has not changed since you applied, and an answer there is an application answer. A test result that arrives in that window belongs in that statement only if the delivery form asks about it. The second is any new application on the same life: an increase in face amount, a reinstatement after a lapse, a replacement policy, or a rider added later with fresh evidence of insurability. Each of those asks underwriting questions again, under the state law in force on that date.

Conversion is a useful exception. A term policy's conversion privilege usually lets you convert to permanent coverage without new evidence of insurability within the contract's window, so a result received after issue does not enter that decision. Our conversion options guide explains the deadlines and what "without evidence" means in a contract.

Florida's subsection (2)(b) bars use of genetic test results "for any insurance purpose," which reaches past the application to claims and administration. Delaware's subsection (b)(3) names "payment of claims." In those two states, a result cannot lawfully be used against an existing policy even at claim time, apart from the carve-outs for diagnoses and records.

Testing before or after you apply

The order of events is a decision only you can make, with your physician and a genetic counselor, and medical value should come first. The insurance consequence depends on the state and on where the result ends up. These are the combinations.

  • Consumer kit, result kept out of your chart, Florida or Delaware applicant. The insurer may not ask for it or use it alone. This is the strongest position in the table.
  • Consumer kit, result kept out of your chart, a state with no specific rule. The insurer may ask on the application whether you have had genetic testing. If it asks, you answer truthfully.
  • Clinical test ordered by your physician, documented in the chart. The record reaches the underwriter through the medical records authorization in every state. In Delaware a result in the chart is outside the protection of subsection (b). In Florida the result itself stays protected, but a resulting diagnosis does not.
  • Any test after the policy is issued. The existing policy is unaffected, apart from the delivery and new-application moments above.

Some people buy coverage before testing so the policy is in place whatever the result shows. That is a legitimate sequence when the application is answered truthfully at the time you sign: a test you have not taken is not a result you hold. What crosses the line is answering "no" to a question about testing after you have tested, or concealing a diagnosis. The underwriting and health hub collects the related application guides.

Where the information can travel

A genetic result can reach an insurer three ways: your answers, your medical records, and a third-party database or data sale. The first two you control by reading the form and the authorization. The third is what the Illinois, South Dakota and Delaware data-sharing provisions address, by requiring your written consent before a consumer testing company shares data with a life insurer, or before a Delaware life insurer obtains it.

The industry's shared database, MIB, holds coded information that insurers report from applications you have made, and you have a federal right to a free copy of your file. Our explainer on what underwriting checks besides your answers walks through MIB, prescription history reports and the records authorization, and shows how to request each one before you apply.

Your own testing company's privacy settings matter too. A consumer DNA service's terms decide whether it may share data with research partners or other third parties; the Illinois and South Dakota statutes add a written-consent layer for insurers specifically. Before you apply, read your testing account's consent and sharing settings, withdraw any research consent you no longer want, and download or delete data as the service allows. South Dakota's 2026 law requires a company to offer a way to revoke consent and to destroy a stored sample within 30 days of a revocation.

A state missing from the table

A state not in the table is not a state without rules. Insurance codes commonly carry a general unfair discrimination clause; Arizona's section 20-448(A), for example, bars "unfair discrimination between individuals of the same class and equal expectation of life" in life insurance rates and terms. How such a clause applies to genetic information depends on that state's own text and regulator. To find the rule that governs your application:

  1. Identify the state whose law governs the policy. That is usually the state where you live and where the policy is delivered, and it appears on the application.
  2. On that state legislature's official code site, search the insurance title for "genetic." Read each section in full, including its definitions and exceptions, and check the source note for the year it took effect.
  3. Check the state insurance department's consumer pages for a bulletin or advisory, as Maryland's Insurance Administration published for its 2025 rules.
  4. Read the insurer's application and medical questionnaire before signing, and note exactly how any genetic testing question is worded.
  5. If the question appears to conflict with your state's law, ask the agent in writing, and contact the state insurance department if the answer does not resolve it.

Then run the quotes you receive through the term quote comparison worksheet, which computes only what you enter, stores nothing and sends nothing, and lines up total paid and cost per $1,000 of coverage side by side.

Sources

DNA results and the application: your questions

Can life insurance companies see my 23andMe or other DNA test results?

Not without a route in. An insurer learns of a consumer DNA result through your application answers, your medical records if the result is in them, or a data transfer from the testing company. Illinois, South Dakota and Delaware require your written consent before a consumer testing company shares data with a life insurer, or before a Delaware insurer obtains it. In states with no specific rule, an insurer may ask about testing on the application, and you must answer truthfully.

Does GINA protect me from life insurance genetic discrimination?

No. GINA (Public Law 110-233) covers health insurance in Title I and employment in Title II. It does not mention life, disability income or long-term care insurance. Protection for life insurance comes from state law.

Which states ban life insurers from using genetic test results?

As read on October 31, 2026: Florida (section 627.4301) bars life insurers from requiring, soliciting or using genetic test results for any insurance purpose. Delaware (18 Del. C. 2317A, approved October 9, 2024) bars decisions based solely on a genetic test and requests for consumer DNA data. Maryland requires consent and an actuarial link to risk and bars mandated testing. Diagnoses in the medical record remain usable in all three.

Do I have to tell a life insurer about a DNA test?

Only if the application asks, and not in Florida, where insurers may not solicit genetic information. If a question about genetic testing appears in a state that permits it, a false answer is a misstatement that can be raised during the contestable period. If nothing asks, you have no duty to volunteer a result, but diagnoses must be disclosed under the ordinary medical questions.

Can a genetic test affect a life insurance policy I already have?

No. An issued policy keeps its premium schedule and terms, and the insurer has no right to re-underwrite it because of later health information. A new application, face amount increase, reinstatement or replacement asks underwriting questions again under the law in force on that date.

Did Vermont pass a law banning genetic discrimination in life insurance?

Not as of October 31, 2026. S.247 passed the Vermont Senate in 2022, but the legislature's bill status page shows no act for it. Vermont's existing rule, 18 V.S.A. 9334 (effective January 1, 1999), bars conditioning a policy on a requirement to take a genetic test or on a family member's results.

Can a life insurer ask about family history if it cannot ask about genetic tests?

Yes. Florida's definition of genetic information excludes questions about family history, Delaware's protection does not reach pertinent family history, and Rhode Island's 2026 bill expressly keeps family history questions. Answer them from what you know of relatives' diagnoses.